Compared to several other metal ions with similar chemical properties, zinc is relatively harmless. Only exposure to high doses has toxic effects, making acute zinc intoxication a rare event. In addition to acute intoxication, long-term, high-dose zinc supplementation interferes with the uptake of copper. Hence, many of its toxic effects are in fact due to copper deficiency. While systemic homeostasis and efficient regulatory mechanisms on the cellular level generally prevent the uptake of cytotoxic doses of exogenous zinc, endogenous zinc plays a significant role in cytotoxic events in single cells. Here, zinc influences apoptosis by acting on several molecular regulators of programmed cell death, including caspases and proteins from the Bcl and Bax families. One organ where zinc is prominently involved in cell death is the brain, and cytotoxicity in consequence of ischemia or trauma involves the accumulation of free zinc. Rather than being a toxic metal ion, zinc is an essential trace element. Whereas intoxication by excessive exposure is rare, zinc deficiency is widespread and has a detrimental impact on growth, neuronal development, and immunity, and in severe cases its consequences are lethal. Zinc deficiency caused by malnutrition and foods with low bioavailability, aging, certain diseases, or deregulated homeostasis is a far more common risk to human health than intoxication.
References
[1]
Fosmire, GJ. Zinc toxicity. Am. J. Clin. Nutr？1990, 51, 225–227.
[2]
U. S. National Library of Medicine, Toxnet Database.
[3]
Jones, MM; Schoenheit, JE; Weaver, AD. Pretreatment and heavy metal LD50 values. Toxicol. Appl. Pharmacol？1979, 49, 41–44.
[4]
Vallee, BL; Falchuk, KH. The biochemical basis of zinc physiology. Physiol. Rev？1993, 73, 79–118.
[5]
Wastney, ME; Aamodt, RL; Rumble, WF; Henkin, RI. Kinetic analysis of zinc metabolism and its regulation in normal humans. Am. J. Physiol？1986, 251, R398–R408.
[6]
Bentley, PJ; Grubb, BR. Experimental dietary hyperzincemia tissue disposition of excess zinc in rabbits. Trace. Elem. Med？1991, 8, 202–207.
[7]
He, LS; Yan, XS; Wu, DC. Age-dependent variation of zinc-65 metabolism in LACA mice. Int J. Radiat. Biol？1991, 60, 907–916.
[8]
Llobet, JM; Domingo, JL; Colomina, MT; Mayayo, E; Corbella, J. Subchronic oral toxicity of zinc in rats. Bull. Environ. Contam. Toxicol？1988, 41, 36–43.
[9]
Scott, BJ; Bradwell, AR. Identification of the serum binding proteins for iron, zinc, cadmium, nickel, and calcium. Clin. Chem？1983, 29, 629–633.
Haase, H; Maret, W. Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling. Exp. Cell Res？2003, 291, 289–298.
[12]
Taylor, KM; Vichova, P; Jordan, N; Hiscox, S; Hendley, R; Nicholson, RI. ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer Cells. Endocrinology？2008, 149, 4912–4920.
[13]
Chimienti, F; Aouffen, M; Favier, A; Seve, M. Zinc homeostasis-regulating proteins: new drug targets for triggering cell fate. Curr. Drug Targets？2003, 4, 323–338.
[14]
Tapiero, H; Tew, KD. Trace elements in human physiology and pathology: zinc and metallothioneins. Biomed. Pharmacother？2003, 57, 399–411.
[15]
Krezel, A; Maret, W. Dual nanomolar and picomolar Zn(II) binding properties of metallothionein. J. Am. Chem. Soc？2007, 129, 10911–10921.
[16]
Laity, JH; Andrews, GK. Understanding the mechanisms of zinc-sensing by metal-response element binding transcription factor-1 (MTF-1). Arch. Biochem. Biophys？2007, 463, 201–210.
[17]
Maret, W. Zinc coordination environments in proteins as redox sensors and signal transducers. Antioxid. Redox. Signal？2006, 8, 1419–1441.
[18]
Toxicological Profile for Zinc; Agency for Toxic Substances and Disease Registry Division of Toxicology and Environmental Medicine: Atlanta, GA, USA, 2005.
[19]
Homma, S; Jones, R; Qvist, J; Zapol, WM; Reid, L. Pulmonary vascular lesions in the adult respiratory distress syndrome caused by inhalation of zinc chloride smoke: a morphometric study. Hum. Pathol？1992, 23, 45–50.
[20]
Freitag, A; Caduff, B. ARDS caused by military zinc fumes exposure. Schweiz Med. Wochenschr？1996, 126, 1006–1010.
[21]
Johnson, FA; Stonehill, RB. Chemical pneumonitis from inhalation of zinc chloride. Dis. Chest？1961, 40, 619–624.
Vogelmeier, C; Konig, G; Bencze, K; Fruhmann, G. Pulmonary involvement in zinc fume fever. Chest？1987, 92, 946–948.
[24]
Rohrs, LC. Metal-fume fever from inhaling zinc oxide. AMA Arch. Ind. Health？1957, 16, 42–47.
[25]
Brown, JJ. Zinc fume fever. Br. J. Radiol？1988, 61, 327–329.
[26]
Martin, CJ; Le, XC; Guidotti, TL; Yalcin, S; Chum, E; Audette, RJ; Liang, C; Yuan, B; Zhang, X; Wu, J. Zinc exposure in Chinese foundry workers. Am. J. Ind. Med？1999, 35, 574–580.
[27]
Sturgis, CC; Drinker, P; Thompson, RM. Metal fume fever: I. Clinical observations on the effect of the experimental inhalation of zinc oxide by two apparently normal persons. J. Ind. Hyg？1927, 9, 88–97.
[28]
Hammond, JW. Metal fume fever in crushed stone industry. J. Ind. Hyg？1944, 26, 117–119.
[29]
Blanc, P; Wong, H; Bernstein, MS; Boushey, HA. An experimental human model of metal fume fever. Ann. Intern. Med？1991, 114, 930–936.
[30]
Drinker, P; Thompson, RM; Finn, JL. Metal fume fever: IV. Threshold doses of zinc oxide, preventive measures, and the chronic effects of repeated exposures. J. Ind. Hyg？1927, 9, 331–345.
[31]
Marquart, H; Smid, T; Heederik, D; Visschers, M. Lung function of welders of zinc-coated mild steel: cross-sectional analysis and changes over five consecutive work shifts. Am. J. Ind. Med？1989, 16, 289–296.
[32]
OSHA. Occupational Safety and Health Standards; Occupational Safety and Health Administration: Washington, DC, USA, 2003; Volume 29.
[33]
Agren, MS. Percutaneous absorption of zinc from zinc oxide applied topically to intact skin in man. Dermatologica？1990, 180, 36–39.
[34]
Agren, MS; Krusell, M; Franzen, L. Release and absorption of zinc from zinc oxide and zinc sulfate in open wounds. Acta Dermato.-Venereol？1991, 71, 330–333.
[35]
Lansdown, AB. Interspecies variations in response to topical application of selected zinc compounds. Food. Chem. Toxicol？1991, 29, 57–64.
[36]
Agren, MS; Franzen, L; Chvapil, M. Effects on wound healing of zinc oxide in a hydrocolloid dressing. J. Am. Acad. Dermatol？1993, 29, 221–227.
[37]
Lansdown, AB. Influence of zinc oxide in the closure of open skin wounds. Int. J. Cosmet. Sci？1993, 15, 83–85.
[38]
Stromberg, HE; Agren, MS. Topical zinc oxide treatment improves arterial and venous leg ulcers. Br. J. Dermatol？1984, 111, 461–468.
[39]
Trumbo, P; Yates, AA; Schlicker, S; Poos, M. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J. Am. Diet. Assoc？2001, 101, 294–301.
Fox, MRS. Zinc excess. In Zinc in Human Biology; Mills, CF, Ed.; Springer Verlag: New York, NY, USA, 1989; pp. 366–368.
[42]
Porea, TJ; Belmont, JW; Mahoney, DH, Jr. Zinc-induced anemia and neutropenia in an adolescent. J. Pediatr？2000, 136, 688–690.
[43]
Samman, S; Roberts, DC. The effect of zinc supplements on plasma zinc and copper levels and the reported symptoms in healthy volunteers. Med. J. Aust？1987, 146, 246–249.
[44]
Haase, H; Overbeck, S; Rink, L. Zinc supplementation for the treatment or prevention of disease: current status and future perspectives. Exp. Gerontol？2008, 43, 394–408.
[45]
Callender, GR; Gentzkow, CJ. Acute poisoning by the zinc and antimony content of limeade prepared in a galvanized iron can. Military Surgeon？1937, 80, 67–71.
[46]
Lewis, MR; Kokan, L. Zinc gluconate: acute ingestion. J. Toxicol. Clin. Toxicol？1998, 36, 99–101.
Magee, AC; Matrone, G. Studies on growth, copper metabolism of rats fed high levels of zinc. J. Nutr？1960, 72, 233–242.
[49]
Ogiso, T; Moriyama, K; Sasaki, S; Ishimura, Y; Minato, A. Inhibitory effect of high dietary zinc on copper absorption in rats. Chem. Pharm. Bull. (Tokyo)？1974, 22, 55–60.
[50]
Van Campen, DR. Copper interference with the intestinal absorption of zinc-65 by rats. J. Nutr？1969, 97, 104–108.
[51]
Igic, PG; Lee, E; Harper, W; Roach, KW. Toxic effects associated with consumption of zinc. Mayo. Clin. Proc？2002, 77, 713–716.
[52]
Ogiso, T; Ogawa, N; Miura, T. Inhibitory effect of high dietary zinc on copper absorption in rats. II. Binding of copper and zinc to cytosol proteins in the intestinal mucosa. Chem. Pharm. Bull？1979, 27, 515–521.
[53]
Oestreicher, P; Cousins, RJ. Copper and zinc absorption in the rat: mechanism of mutual antagonism. J. Nutr？1985, 115, 159–166.
[54]
Fischer, PW; Giroux, A; L’Abbe, MR. The effect of dietary zinc on intestinal copper absorption. Am. J. Clin. Nutr？1981, 34, 1670–1675.
[55]
Fiske, DN; McCoy, HE, III; Kitchens, CS. Zinc-induced sideroblastic anemia: report of a case, review of the literature, and description of the hematologic syndrome. Am. J. Hematol？1994, 46, 147–150.
[56]
Prohaska, JR. Biochemical changes in copper deficiency. J. Nutr. Biochem？1990, 1, 452–461.
[57]
Sandstead, HH. Requirements and toxicity of essential trace elements, illustrated by zinc and copper. Am. J. Clin. Nutr？1995, 61, 621S–624S.
[58]
Irving, JA; Mattman, A; Lockitch, G; Farrell, K; Wadsworth, LD. Element of caution: a case of reversible cytopenias associated with excessive zinc supplementation. CMAJ？2003, 169, 129–131.
[59]
Prasad, AS; Brewer, GJ; Schoomaker, EB; Rabbani, P. Hypocupremia induced by zinc therapy in adults. JAMA？1978, 240, 2166–2168.
[60]
Broun, ER; Greist, A; Tricot, G; Hoffman, R. Excessive zinc ingestion: a reversible cause of sideroblastic anemia and bone marrow depression. JAMA？1990, 265, 1441–1443.
[61]
Frieden, E. The copper connection. Semin. Hematol？1983, 20, 114–117.
[62]
Willis, MS; Monaghan, SA; Miller, ML; McKenna, RW; Perkins, WD; Levinson, BS; Bhushan, V; Kroft, SH. Zinc-induced copper deficiency: a report of three cases initially recognized on bone marrow examination. Am. J. Clin. Pathol？2005, 123, 125–131.
[63]
Williams, DM. Copper deficiency in humans. Semin. Hematol？1983, 20, 118–128.
Foster, M; Petocz, P; Samman, S. Effects of zinc on plasma lipoprotein cholesterol concentrations in humans: A meta-analysis of randomised controlled trials. Atherosclerosis？2009.
[66]
Black, MR; Medeiros, DM; Brunett, E; Welke, R. Zinc supplements and serum lipids in young adult white males. Am. J. Clin. Nutr？1988, 47, 970–975.
Freeland-Graves, JH; Friedman, BJ; Han, WH; Shorey, RL; Young, R. Effect of zinc supplementation on plasma high-density lipoprotein cholesterol and zinc. Am. J. Clin. Nutr？1982, 35, 988–992.
[69]
Reiser, S; Powell, AS; Yang, C; Canary, J. Effect of copper intake on blood cholesterol and its lipoprotein distribution in men. Nutr. Rep. Int？1987, 36, 641–649.
[70]
Klevay, LM; Inman, L; Johnson, LK; Lawler, M; Mahalko, JR; Milne, DB; Lukaski, HC; Bolonchuk, W; Sandstead, HH. Increased cholesterol in plasma in a young man during experimental copper depletion. Metabolism？1984, 33, 1112–1118.
[71]
Beyersmann, D; Hartwig, A. Carcinogenic metal compounds: recent insight into molecular and cellular mechanisms. Arch. Toxicol？2008, 82, 493–512.
[72]
Costello, LC; Franklin, RB. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate？1998, 35, 285–296.
[73]
Habib, FK. Zinc and the steroid endocrinology of the human prostate. J. Steroid. Biochem？1978, 9, 403–407.
[74]
Zaichick, V; Sviridova, TV; Zaichick, SV. Zinc in the human prostate gland: normal, hyperplastic and cancerous. Int. Urol. Nephrol？1997, 29, 565–574.
[75]
Costello, LC; Liu, Y; Zou, J; Franklin, RB. Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone. J. Biol. Chem？1999, 274, 17499–17504.
Jarrard, DF. Does zinc supplementation increase the risk of prostate cancer? Arch. Ophthalmol？2005, 123, 102–103.
[78]
Leitzmann, MF; Stampfer, MJ; Wu, K; Colditz, GA; Willett, WC; Giovannucci, EL. Zinc supplement use and risk of prostate cancer. J. Natl. Cancer Inst？2003, 95, 1004–1007.
[79]
Honscheid, A; Rink, L; Haase, H. T-lymphocytes: a target for stimulatory and inhibitory effects of zinc ions. Endocr. Metab. Immune Disord. Drug Targets？2009, 9, 132–144.
[80]
Rink, L; Gabriel, P. Zinc and the immune system. Proc. Nutr. Soc？2000, 59, 541–552.
[81]
Delafuente, JC. Nutrients and immune responses. Rheum. Dis. Clin. North Am？1991, 17, 203–212.
[82]
Fraker, PJ; DePasquale-Jardieu, P; Zwickl, CM; Luecke, RW. Regeneration of T-cell helper function in zinc-deficient adult mice. Proc. Nat. Acad. Sci. USA？1978, 75, 5660–5664.
[83]
Haase, H; Rink, L. Functional significance of zinc-related signaling pathways in immune cells. Annu. Rev. Nutr？2009, 29, 133–152.
[84]
Wellinghausen, N; Driessen, C; Rink, L. Stimulation of human peripheral blood mononuclear cells by zinc and related cations. Cytokine？1996, 8, 767–771.
[85]
Bulgarini, D; Habetswallner, D; Boccoli, G; Montesoro, E; Camagna, A; Mastroberardino, G; Rosania, C; Testa, U; Peschle, C. Zinc modulates the mitogenic activation of human peripheral blood lymphocytes. Ann. Ist. Super. Sanita？1989, 25, 463–470.
[86]
Wellinghausen, N; Martin, M; Rink, L. Zinc inhibits interleukin-1-dependent T cell stimulation. Eur. J. Immunol？1997, 27, 2529–2535.
[87]
Campo, CA; Wellinghausen, N; Faber, C; Fischer, A; Rink, L. Zinc inhibits the mixed lymphocyte culture. Biol. Tr. Elem. Res？2001, 79, 15–22.
[88]
Faber, C; Gabriel, P; Ibs, KH; Rink, L. Zinc in pharmacological doses suppresses allogeneic reaction without affecting the antigenic response. Bone Marrow Transplant？2004, 33, 1241–1246.
[89]
Duchateau, J; Delepesse, G; Vrijens, R; Collet, H. Beneficial effects of oral zinc supplementation on the immune response of old people. Am. J. Med？1981, 70, 1001–1004.
[90]
Cummings, JE; Kovacic, JP. The ubiquitous role of zinc in health and disease. J. Vet. Emerg. Crit. Care？2009, 19, 215–240.
[91]
Formigari, A; Irato, P; Santon, A. Zinc, antioxidant systems and metallothionein in metal mediated-apoptosis: biochemical and cytochemical aspects. Comp. Biochem. Physiol. Pt. C？2007, 146, 443–459.
[92]
Haase, H; Watjen, W; Beyersmann, D. Zinc induces apoptosis that can be suppressed by lanthanum in C6 rat glioma cells. Biol. Chem？2001, 382, 1227–1234.
[93]
Truong-Tran, AQ; Carter, J; Ruffin, RE; Zalewski, PD. The role of zinc in caspase activation and apoptotic cell death. Biometals？2001, 14, 315–330.
[94]
Fraker, PJ; Telford, WG. A reappraisal of the role of zinc in life and death decisions of cells. Proc. Soc. Exp. Biol. Med？1997, 215, 229–236.
[95]
Watjen, W; Haase, H; Biagioli, M; Beyersmann, D. Induction of apoptosis in mammalian cells by cadmium and zinc. Environ. Health Perspect？2002, 110, 865–867.
[96]
Kim, YH; Kim, EY; Gwag, BJ; Sohn, S; Koh, JY. Zinc-induced cortical neuronal death with features of apoptosis and necrosis: mediation by free radicals. Neuroscience？1999, 89, 175–182.
[97]
McLaughlin, B; Pal, S; Tran, MP; Parsons, AA; Barone, FC; Erhardt, JA; Aizenman, E. p38 activation is required upstream of potassium current enhancement and caspase cleavage in thiol oxidant-induced neuronal apoptosis. J. Neurosci？2001, 21, 3303–3311.
[98]
Wiseman, DA; Wells, SM; Wilham, J; Hubbard, M; Welker, JE; Black, SM. Endothelial response to stress from exogenous Zn2+ resembles that of NO-mediated nitrosative stress, and is protected by MT-1 overexpression. Am. J. Physiol. Cell Physiol？2006, 291, C555–568.
[99]
Brown, AM; Kristal, BS; Effron, MS; Shestopalov, AI; Ullucci, PA; Sheu, KF; Blass, JP; Cooper, AJ. Zn2+ inhibits alpha-ketoglutarate-stimulated mitochondrial respiration and the isolated alpha-ketoglutarate dehydrogenase complex. J. Biol. Chem？2000, 275, 13441–13447.
[100]
Sheline, CT; Behrens, MM; Choi, DW. Zinc-induced cortical neuronal death: contribution of energy failure attributable to loss of NAD(+) and inhibition of glycolysis. J. Neurosci？2000, 20, 3139–3146.
[101]
Feng, P; Li, T; Guan, Z; Franklin, RB; Costello, LC. The involvement of Bax in zinc-induced mitochondrial apoptogenesis in malignant prostate cells. Mol. Cancer？2008, 7, 25.
[102]
Dineley, KE; Votyakova, TV; Reynolds, IJ. Zinc inhibition of cellular energy production: implications for mitochondria and neurodegeneration. J. Neurochem？2003, 85, 563–570.
[103]
Feng, P; Li, TL; Guan, ZX; Franklin, RB; Costello, LC. Direct effect of zinc on mitochondrial apoptogenesis in prostate cells. Prostate？2002, 52, 311–318.
[104]
Mills, DA; Schmidt, B; Hiser, C; Westley, E; Ferguson-Miller, S. Membrane potential-controlled inhibition of cytochrome c oxidase by zinc. J. Biol. Chem？2002, 277, 14894–14901.
[105]
Bitanihirwe, BK; Cunningham, MG. Zinc: the brain’s dark horse. Synapse？2009, 63, 1029–1049.
[106]
Cui, L; Takagi, Y; Sando, K; Wasa, M; Okada, A. Nitric oxide synthase inhibitor attenuates inflammatory lesions in the skin of zinc-deficient rats. Nutrition？2000, 16, 34–41.
[107]
Cui, L; Takagi, Y; Wasa, M; Sando, K; Khan, J; Okada, A. Nitric oxide synthase inhibitor attenuates intestinal damage induced by zinc deficiency in rats. J. Nutr？1999, 129, 792–798.
Williams, RJP. The biochemistry of zinc. Polyhedron？1987, 6, 61–69.
[110]
Perry, DK; Smyth, MJ; Stennicke, HR; Salvesen, GS; Duriez, P; Poirier, GG; Hannun, YA. Zinc is a potent inhibitor of the apoptotic protease, caspase-3. A novel target for zinc in the inhibition of apoptosis. J. Biol. Chem？1997, 272, 18530–18533.
[111]
Maret, W; Jacob, C; Vallee, BL; Fischer, EH. Inhibitory sites in enzymes: zinc removal and reactivation by thionein. Proc. Nat. Acad. Sci. USA？1999, 96, 1936–1940.
[112]
Stennicke, HR; Salvesen, GS. Biochemical characteristics of caspases-3, -6, -7, and -8. J. Biol. Chem？1997, 272, 25719–25723.
Fukamachi, Y; Karasaki, Y; Sugiura, T; Itoh, H; Abe, T; Yamamura, K; Higashi, K. Zinc suppresses apoptosis of U937 cells induced by hydrogen peroxide through an increase of the Bcl-2/Bax ratio. Biochem. Biophys. Res. Commun？1998, 246, 364–369.
[115]
Zalewski, PD; Forbes, IJ; Giannakis, C. Physiological role for zinc in prevention of apoptosis (gene-directed death). Biochem. Int？1991, 24, 1093–1101.
[116]
Zalewski, PD; Forbes, IJ; Betts, WH. Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-methyl-8-p-toluenesulphonamido-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). Biochem. J？1993, 296, 403–408.
[117]
Murphy, JV. Intoxication following ingestion of elemental zinc. JAMA？1970, 212, 2119–2120.
[118]
Colvin, RA; Fontaine, CP; Laskowski, M; Thomas, D. Zn2+ transporters and Zn2+ homeostasis in neurons. Eur. J. Pharmacol？2003, 479, 171–185.
[119]
Frederickson, CJ; Bush, AI. Synaptically released zinc: physiological functions and pathological effects. Biometals？2001, 14, 353–366.
[120]
Takeda, A. Movement of zinc and its functional significance in the brain. Brain. Res. Rev？2000, 34, 137–148.
[121]
Vogt, K; Mellor, J; Tong, G; Nicoll, R. The actions of synaptically released zinc at hippocampal mossy fiber synapses. Neuron？2000, 26, 187–196.
[122]
Cuajungco, MP; Lees, GJ. Zinc and Alzheimer’s disease: is there a direct link? Brain. Res. Rev？1997, 23, 219–236.
[123]
Cuajungco, MP; Lees, GJ. Zinc metabolism in the brain: relevance to human neurodegenerative disorders. Neurobiol. Disease？1997, 4, 137–169.
[124]
Frederickson, CJ; Suh, SW; Silva, D; Thompson, RB. Importance of zinc in the central nervous system: the zinc-containing neuron. J. Nutr？2000, 130, 1471S–1483S.
[125]
Duncan, MW; Marini, AM; Watters, R; Kopin, IJ; Markey, SP. Zinc, a neurotoxin to cultured neurons, contaminates cycad flour prepared by traditional guamanian methods. J. Neurosci？1992, 12, 1523–1537.
[126]
Choi, DW; Yokoyama, M; Koh, J. Zinc neurotoxicity in cortical cell culture. Neuroscience？1988, 24, 67–79.
[127]
Frederickson, CJ. Neurobiology of zinc and zinc-containing neurons. Int. Rev. Neurobiol？1989, 31, 145–238.
[128]
Koh, JY; Choi, DW. Zinc toxicity on cultured cortical neurons: involvement of N-methyl-D-aspartate receptors. Neuroscience？1994, 60, 1049–1057.
[129]
Wang, YX; Quastel, DM. Multiple actions of zinc on transmitter release at mouse end-plates. Pflugers. Arch.-Eur. J. Physiol？1990, 415, 582–587.
[130]
Colvin, RA; Davis, N; Nipper, RW; Carter, PA. Zinc transport in the brain: routes of zinc influx and efflux in neurons. J. Nutr？2000, 130, 1484S–1487S.
Sensi, SL; Ton-That, D; Weiss, JH. Mitochondrial sequestration and Ca(2+)-dependent release of cytosolic Zn(2+) loads in cortical neurons. Neurobiol. Disease？2002, 10, 100–108.
[134]
Masters, BA; Quaife, CJ; Erickson, JC; Kelly, EJ; Froelick, GJ; Zambrowicz, BP; Brinster, RL; Palmiter, RD. Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles. J. Neurosci？1994, 14, 5844–5857.
[135]
Palmiter, RD; Findley, SD; Whitmore, TE; Durnam, DM. MT-III, a brain-specific member of the metallothionein gene family. Proc. Nat. Acad. Sci. USA？1992, 89, 6333–6337.
[136]
Yokoyama, M; Koh, J; Choi, DW. Brief exposure to zinc is toxic to cortical neurons. Neurosci. Lett？1986, 71, 351–355.
[137]
Frederickson, CJ; Klitenick, MA; Manton, WI; Kirkpatrick, JB. Cytoarchitectonic distribution of zinc in the hippocampus of man and the rat. Brain. Res？1983, 273, 335–339.
[138]
Assaf, SY; Chung, SH. Release of endogenous Zn2+ from brain tissue during activity. Nature？1984, 308, 734–736.
[139]
Sloviter, RS. A selective loss of hippocampal mossy fiber Timm stain accompanies granule cell seizure activity induced by perforant path stimulation. Brain. Res？1985, 330, 150–153.
[140]
Siesjo, BK. Basic mechanisms of traumatic brain damage. Ann. Emerg. Med？1993, 22, 959–969.
[141]
Frederickson, CJ; Koh, JY; Bush, AI. The neurobiology of zinc in health and disease. Nat. Rev. Neurosci？2005, 6, 449–462.
Weiss, JH; Sensi, SL; Koh, JY. Zn(2+): a novel ionic mediator of neural injury in brain disease. Trends. Pharmacol. Sci？2000, 21, 395–401.
[144]
Tonder, N; Johansen, FF; Frederickson, CJ; Zimmer, J; Diemer, NH. Possible role of zinc in the selective degeneration of dentate hilar neurons after cerebral ischemia in the adult rat. Neurosci. Lett？1990, 109, 247–252.
[145]
Koh, JY; Suh, SW; Gwag, BJ; He, YY; Hsu, CY; Choi, DW. The role of zinc in selective neuronal death after transient global cerebral ischemia. Science？1996, 272, 1013–1016.
[146]
Suh, SW; Chen, JW; Motamedi, M; Bell, B; Listiak, K; Pons, NF; Danscher, G; Frederickson, CJ. Evidence that synaptically-released zinc contributes to neuronal injury after traumatic brain injury. Brain. Res？2000, 852, 268–273.
[147]
Lee, JY; Cole, TB; Palmiter, RD; Koh, JY. Accumulation of zinc in degenerating hippocampal neurons of ZnT3-null mice after seizures: evidence against synaptic vesicle origin. J Neurosci？2000, 20, RC79.
[148]
Jiang, D; Sullivan, PG; Sensi, SL; Steward, O; Weiss, JH. Zn(2+) induces permeability transition pore opening and release of pro-apoptotic peptides from neuronal mitochondria. J. Biol. Chem？2001, 276, 47524–47529.
[149]
Sensi, SL; Ton-That, D; Sullivan, PG; Jonas, EA; Gee, KR; Kaczmarek, LK; Weiss, JH. Modulation of mitochondrial function by endogenous Zn2+ pools. Proc. Nat. Acad. Sci. USA？2003, 100, 6157–6162.
[150]
Kim, EY; Koh, JY; Kim, YH; Sohn, S; Joe, E; Gwag, BJ. Zn2+ entry produces oxidative neuronal necrosis in cortical cell cultures. Eur. J. Neurosci？1999, 11, 327–334.
Noh, KM; Koh, JY. Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes. J Neurosci？2000, 20, RC111.
[153]
Seo, SR; Chong, SA; Lee, SI; Sung, JY; Ahn, YS; Chung, KC; Seo, JT. Zn2+-induced ERK activation mediated by reactive oxygen species causes cell death in differentiated PC12 cells. J. Neurochem？2001, 78, 600–610.
[154]
Aizenman, E; Stout, AK; Hartnett, KA; Dineley, KE; McLaughlin, B; Reynolds, IJ. Induction of neuronal apoptosis by thiol oxidation: putative role of intracellular zinc release. J. Neurochem？2000, 75, 1878–1888.
[155]
Wei, G; Hough, CJ; Li, Y; Sarvey, JM. Characterization of extracellular accumulation of Zn2+ during ischemia and reperfusion of hippocampus slices in rat. Neuroscience？2004, 125, 867–877.
Park, JA; Lee, JY; Sato, TA; Koh, JY. Co-induction of p75NTR and p75NTR-associated death executor in neurons after zinc exposure in cortical culture or transient ischemia in the rat. J. Neurosci？2000, 20, 9096–9103.
[158]
Mukai, J; Hachiya, T; Shoji-Hoshino, S; Kimura, MT; Nadano, D; Suvanto, P; Hanaoka, T; Li, Y; Irie, S; Greene, LA; Sato, TA. NADE, a p75NTR-associated cell death executor, is involved in signal transduction mediated by the common neurotrophin receptor p75NTR. J. Biol. Chem？2000, 275, 17566–17570.
[159]
Lobner, D; Canzoniero, LM; Manzerra, P; Gottron, F; Ying, H; Knudson, M; Tian, M; Dugan, LL; Kerchner, GA; Sheline, CT; Korsmeyer, SJ; Choi, DW. Zinc-induced neuronal death in cortical neurons. Cell. Mol. Biol？2000, 46, 797–806.
[160]
Manev, H; Kharlamov, E; Uz, T; Mason, RP; Cagnoli, CM. Characterization of zinc-induced neuronal death in primary cultures of rat cerebellar granule cells. Exp. Neurol？1997, 146, 171–178.
[161]
Barkalifa, R; Hershfinkel, M; Friedman, JE; Kozak, A; Sekler, I. The lipophilic zinc chelator DP-b99 prevents zinc induced neuronal death. Eur. J. Pharmacol？2009, 618, 15–21.
[162]
Devirgiliis, C; Zalewski, PD; Perozzi, G; Murgia, C. Zinc fluxes and zinc transporter genes in chronic diseases. Mutat. Res？2007, 622, 84–93.
[163]
Sensi, SL; Paoletti, P; Bush, AI; Sekler, I. Zinc in the physiology and pathology of the CNS. Nat. Rev. Neurosci？2009, 10, 780–791.
[164]
Ackland, ML; Michalczyk, A. Zinc deficiency and its inherited disorders: a review. Genes. Nutr？2006, 1, 41–49.
Prasad, AS; Halsted, JA; Nadimi, M. Syndrome of iron deficiency anemia, hepatosplenomegaly, hypogonadism, dwarfism and geophagia. Am. J. Med？1961, 31, 532–546.
[167]
Prasad, AS; Miale, AJ; Farid, Z; Sandstead, HH; Schulert, AR. Zinc metabolism in patients with the symptoms of iron deficiency, anaemia, hepatosplenomegaly, dwarfism and hypogonadism. J. Lab. Clin. Med？1963, 61, 537–549.
[168]
Sandstead, HH. Zinc deficiency. A public health problem? Am. J. Dis. Child？1991, 145, 853–859.
[169]
Wang, K; Zhou, B; Kuo, YM; Zemansky, J; Gitschier, J. A novel member of a zinc transporter family is defective in acrodermatitis enteropathica. Am. J. Hum. Genet？2002, 71, 66–73.
[170]
Aggett, PJ. Acrodermatitis enteropathica. J. Inherit. Metab. Dis？1983, 6, 39–43.
[171]
Failla, ML; van de Veerdonk, M; Morgan, WT; Smith, JC, Jr. Characterization of zinc-binding proteins of plasma in familial hyperzincemia. J. Lab. Clin. Med？1982, 100, 943–952.
[172]
Fessatou, S; Fagerhol, MK; Roth, J; Stamoulakatou, A; Kitra, V; Hadarean, M; Paleologos, G; Chandrinou, H; Sampson, B; Papassotiriou, I. Severe anemia and neutropenia associated with hyperzincemia and hypercalprotectinemia. J. Pediatr. Hematol. Oncol？2005, 27, 477–480.
Saito, Y; Saito, K; Hirano, Y; Ikeya, K; Suzuki, H; Shishikura, K; Manno, S; Takakuwa, Y; Nakagawa, K; Iwasa, A; Fujikawa, S; Moriya, M; Mizoguchi, N; Golden, BE; Osawa, M. Hyperzincemia with systemic inflammation: a heritable disorder of calprotectin metabolism with rheumatic manifestations? J. Pediatr？2002, 140, 267–269.
[175]
Sampson, B; Kovar, IZ; Rauscher, A; Fairweather-Tait, S; Beattie, J; McArdle, HJ; Ahmed, R; Green, C. A case of hyperzincemia with functional zinc depletion: a new disorder? Pediatr. Res？1997, 42, 219–225.
[176]
Prasad, AS. Zinc deficiency and effects of zinc supplementation on sickle cell anemia subjects. Prog. Clin. Biol. Res？1981, 55, 99–122.
[177]
Prasad, AS. Zinc deficiency in patients with sickle cell disease. Am. J. Clin. Nutr？2002, 75, 181–182.
[178]
Dardenne, M; Savino, W; Wade, S; Kaiserlian, D; Lemonnier, D; Bach, JF. In vivo and in vitro studies of thymulin in marginally zinc-deficient mice. Eur. J. Immunol？1984, 14, 454–458.
[179]
Wuehler, SE; Peerson, JM; Brown, KH. Use of national food balance data to estimate the adequacy of zinc in national food supplies: methodology and regional estimates. Public Health Nutr？2005, 8, 812–819.
[180]
Cavdar, AO; Arcasoy, A; Cin, S; Babacan, E; Gozdasoglu, S. Geophagia in Turkey: iron and zinc deficiency, iron and zinc absorption studies and response to treatment with zinc in geophagia cases. Prog. Clin. Biol. Res？1983, 129, 71–97.
[181]
Cavdar, OA. Zinc deficiency and geophagia. J. Pediatr？1982, 100, 1003–1004.
[182]
Prasad, AS; Miale, A, Jr; Farid, Z; Sandstead, HH; Schulert, AR. Zinc metabolism in patients with the syndrome of iron deficiency anemia, hepatosplenomegaly, dwarfism, and hypognadism. J. Lab. Clin. Med？1963, 61, 537–549.
[183]
Briefel, RR; Bialostosky, K; Kennedy-Stephenson, J; McDowell, MA; Ervin, RB; Wright, JD. Zinc intake of the U.S. population: findings from the third National Health and Nutrition Examination Survey, 1988–1994. J. Nutr？2000, 130, 1367S–1373S.
